
Yu Mi Kang on the PCSK9 inhibitor Evolocumab & the FOURIER Trial, Neda Rasouli with insights on semaglutide in symptomatic peripheral artery disease & the STRIDE Trial, and more!
Episode 37
Welcome to episode no. 35 (September 2025) of Diabetes Care "On Air"—a new and different way to bring the research published in Diabetes Care to life. Join co-hosts Alice Cheng, MD, FRCPC, and Michael Rickels, MD, MS, as they discuss the latest and greatest content in the September 2025 issue of Diabetes Care and beyond. 3:05 Alice is joined by Yu Mi Kang, MD, PhD, endocrinologist at Brigham and Women's Hospital and instructor at Harvard University in Boston. The discuss her article, "Cardiovascular Outcomes and Efficacy of the PCSK9 Inhibitor Evolocumab in Individuals With Type 1 Diabetes: Insights From the FOURIER Trial," available for free at doi.org/10.2337/dc25-0942. 14:10 Mike speaks with Neda Rasouli, MD, Professor of Medicine in the Division of Endocrinology, Metabolism, and Diabetes at the University of Anschutz Medical Campus. She shares insights from her article, "Benefit of Semaglutide in Symptomatic Peripheral Artery Disease by Baseline Type 2 Diabetes Characteristics: Insights From STRIDE, a Randomized, Placebo-Controlled, Double-Blind Trial," available for free at doi.org/10.2337/dc25-1082. 27:20 In the "Diabetes Care Rapid Exchange," Alice and Mike wrap up the episode by reviewing several interesting articles in the September 2025 issue of Diabetes Care. Studies highlighted in this segment include: Templeman et al.
Publisher
Diabetes Care "On Air"
Link
a37ae29a-26fa-4a28-8b27-9beef19d824e.libsyn.com/yu-mi-kang-on-the-pcsk9-inhibitor-evolocumab-the-fourier-trial-neda-rasouli-with-insights-on-semaglutide-in-symptomatic-peripheral-artery-disease-the-stride-trial-and-more
Published
September 5, 2025
Duration
42 min
Format
Podcast
Category
Issues · Science
Source
RSS feed
Host
American Diabetes Association
Diabetes Care "On Air"
@diabetescareonair
#yumikang #pcsk9inhibitorevolocumab #symptomaticperipheralartery #lifesciences #medicine
